Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.28 HKD | +4.79% | +13.10% | -10.14% |
04-25 | Abbisko Cayman's Liver Cancer Drug Gets US FDA Orphan Drug Designation | MT |
04-24 | Abbisko Cayman Limited Announces Resignation of Tian Huimin as Joint Company Secretary | CI |
Chart calendar Abbisko Cayman Limited
Upcoming events on Abbisko Cayman Limited
Past events on Abbisko Cayman Limited
11/03/2024 | Q4 2023 Earnings Release |
07/01/2024 23:00 | JPMorgan Healthcare Conference |
03/11/2023 01:00 | SAPA China Meeting |
19/10/2023 | European Society for Medical Oncology Congress - ABSK043 |
19/10/2023 | European Society for Medical Oncology Congress - ABSK-011 |
17/10/2023 09:00 | JP Morgan Global Healthcare Shanghai Conference |
14/10/2023 17:30 | EORTC NCI AACR Conference - Poster No: C130 |
13/10/2023 17:30 | EORTC NCI AACR Conference - Poster No: B151 |
20/09/2023 00:00 | SVB Securities Biopharma Summit |
12/09/2023 02:00 | Topsperity Securities Fall Shanghai Strategy Conference |
07/09/2023 02:00 | Industrial Securities Pharma CEO Forum |
06/09/2023 02:00 | Northeast Securities Fall Beijing Strategy Conference |
31/08/2023 06:00 | Haitong Securities Q3 Pharmaceutical Investment Strategy Conference |
23/08/2023 02:00 | HUAAN Securities Strategy Conference |
15/08/2023 15:53 | Q2 2023 Earnings Release |
19/07/2023 00:00 | TF Securities Xi'an Strategy Conference |
27/06/2023 08:00 | Huachuang Strategy Conference |
14/06/2023 03:00 | Annual General Meeting |
14/03/2023 | Q4 2022 Earnings Release |
21/08/2022 | Interim 2022 Earnings Release |
Annual results
Fiscal Period | December | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|
Net sales Million CNY | Released Forecast Spread | 22,7 10,0 126.82% | 0,00 3,90 - | 19,1 27,5 -30.56% | 168 |
EBITDA Million CNY | Released Forecast Spread | -316 -307 -2.87% | -481 -490 1.68% | -493 -567 13.08% | -48,1 |
EBIT Million CNY | Released Forecast Spread | -328 -314 -4.39% | -497 -502 0.9% | -511 -581 12.1% | -54,7 |
Earnings before Tax (EBT) Million CNY | Released Forecast Spread | -1 810 -1 964 7.82% | -496 -439 -12.79% | -432 -532 18.88% | -50,0 |
Net income Million CNY | Released Forecast Spread | -1 810 -1 963 7.81% | -496 -439 -12.79% | -432 -523 17.46% | -517 |
EPS CNY | Released Forecast Spread | -7,71 -2,28 -238.71% | -0,80 -0,70 -14.23% | -0,67 -0,80 16.37% | -0,82 |
Announcement Date | 18/03/22 | 15/03/23 | 12/03/24 | - |
Quarterly results
Fiscal Period | December | 2022 Q1 | 2022 Q2 | 2022 S1 | 2022 S2 | 2023 S1 | 2023 S2 | 2024 S1 | 2024 S2 |
---|---|---|---|---|---|---|---|---|---|
Net sales Million CNY | Released Forecast Spread | 0,00 | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 19,1 0,00 - | 0,00 0,00 - | 0,00 | 0,00 |
Net income Million CNY | Released Forecast Spread | -223 -365 38.92% | -306 | -390 | |||||
EPS CNY | Released Forecast Spread | -0,35 -0,52 32.69% | -0,37 | -0,45 | |||||
Announcement Date | - | 22/08/22 | 22/08/22 | 15/03/23 | 15/08/23 | 12/03/24 | - | - |
Past sector events for Abbisko Cayman Limited
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- 2256 Stock
- Calendar Abbisko Cayman Limited